Clinical Trial Update: Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab and tremelimumab after radiation in microsatellite stable metastatic colorectal cancer progressing on chemotherapy has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2022-12-05